July 27, 2010 — Computed tomographic colonography (CTC) is a promising technique for colorectal cancer screening and is less invasive than optical colonoscopy. However, it is currently not a ...

CT colonography reduced the incidence of colorectal cancer by up to 75% versus no screening, while stool DNA testing reduced the incidence by 59%. Stool testing was cost-effective relative to no ...

Images of positive CT colonography (CTC) screening examination result in an asymptomatic 67-year-old man. Three-dimensional colon map from CTC (left image) shows the location of two sigmoid polyps ...

Compared to stool DNA testing, researchers found that CT colonography is a cost-saving and clinically effective method for colorectal cancer screening, according to a study was published today in ...

April 1, 2010 — More than 1 in every 200 asymptomatic people undergoing routine screening with computed tomographic colonography (CTC), or "virtual colonoscopy," were found to have a clinically ...

Stool DNA testing climbed sharply after the pandemic began while colonoscopy and fecal immunochemical test use fell, a study of nearly 25 million privately insured Blue Cross Blue Shield beneficiaries ...

When performed every three to five years, CT colonographies may be more effective at catching instances of colon cancer than stool-based tests, according to a June 10 study published in Radiology. The ...

The researchers found that Black adults showed higher CRC cases and greater utilization for FIT over colonoscopy than White adults under the status quo. HealthDay News — In Black adults, computed ...

The American College of Physicians (ACP) updated guidance reaffirming its stance that colorectal cancer screening should wait until age 50 for average-risk, asymptomatic adults. The ACP recommends ...

Images of positive CT colonography (CTC) screening examination result in an asymptomatic 67-year-old man. Three-dimensional colon map from CTC (left image) shows the location of two sigmoid polyps ...

Computed tomography (CT) colonography is a more cost-effective and more clinically effective method for colorectal cancer screening, compared to stool DNA testing (mt-sDNA), new research published in ...